Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Levoglutamide

EU orphan designation number: EU/3/12/1011   
Active ingredient: Levoglutamide
Indication: Treatment of sickle cell disease
Sponsor: Emmaus Medical Europe Limited
The Clockhouse, Station Approach, Marlow, Bucks SL7 1NT, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
06/07/2012 Centralised Orphan - Designation EMA/OD/016/12 (2012)4765 of 04/07/2012